Latest Sustainability News

WAM Capital has reported a robust 14.9% increase in its investment portfolio over six months, outperforming key ASX indices and maintaining its interim dividend at 7.75 cents per share.

Westgold Resources reported a 72% jump in revenue to $624 million in H1 FY25, driven by increased gold production and higher prices, but posted a net loss after tax due to significant one-off acquisition expenses.

Pengana Capital Group reports a rise in Funds Under Management to $3.64 billion as of January 31, 2025, following significant distributions to investors. The firm’s half-year audited results are due next month, setting the stage for further insights.

LGI Limited reports a solid H1 FY25 performance with modest revenue growth and increased EBITDA, driven by expanded biogas flows and carbon abatement activities. The company confirms a positive outlook with a 12-15% underlying EBITDA growth forecast for FY25.

Westgold Resources reports a sharp revenue increase driven by higher gold prices and the Karora acquisition, yet posts a net loss for the half-year ending December 2024. The company also declares a fully franked dividend amid rising costs.

LGI Limited reported a 7% rise in revenue and a 3% increase in EBITDA for H1 FY25, driven by expanded power generation capacity and higher landfill gas flows. However, net profit after tax declined by 22%, reflecting ongoing investment and market dynamics.

Suvo Strategic Minerals has extended its key take or pay Offtake Agreement with Chaozhou Chengcheng Industrial Co., Ltd, increasing minimum hydrous kaolin order volumes by 25% over five years, valued at approximately A$6.56 million.

Abacus Storage King reported a modest 1.1% increase in statutory profit for HY25, underpinned by resilient operating metrics and a robust balance sheet. The company’s multi-pronged growth strategy, including acquisitions and a substantial development pipeline, supports a confident outlook with reaffirmed distribution guidance.

Abacus Storage King (ASK) reported a robust half-year performance for HY25, with net profit soaring to $67.8 million and key operating metrics showing solid growth. The company’s strategic acquisitions, development pipeline, and platform initiatives underpin its confident outlook.

Mirvac's 1H25 results reveal a modest decline in EBIT and operating profit, yet the company signals strong growth prospects fueled by residential sales momentum, sustainable development, and strategic capital partnering.

Mirvac Group reports a 2% revenue increase and a remarkable 100% rise in profit attributable to stapled securityholders for H1 2024, even as operating profit after tax declines by 6%.

Imugene’s Phase 1b trial of azer-cel, an off-the-shelf CD19 CAR T therapy, reports a 57% complete response rate in heavily pretreated diffuse large B-cell lymphoma patients, signaling a promising new option in a challenging cancer landscape.